Meningococcal Group CCRM197 Conjugate Vaccine
Meningococcal Group CCRM197 Conjugate Vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.
Meningococcal group C polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup C. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup C.
| Trade Name | Meningococcal Group CCRM197 Conjugate Vaccine |
| Generic | Meningococcal polysaccharide vaccine group C |
| Meningococcal polysaccharide vaccine group C Other Names | Meningococcal group C polysaccharide, Meningococcal group CCRM197 conjugate vaccine, Meningococcal polysaccharide antigen group C, Neisseria meningitidis group C (strain C11) oligosaccharide CRM-197 adipic acid conjugate, Neisseria meningitidis group C capsular polysaccharide antigen |
| Type | |
| Groups | Approved, Experimental, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Meningococcal Group CCRM197 Conjugate Vaccine
